PBYI earnings: real EPS beat/miss history, analyst consensus Buy, P/E 15.86. Updated 2026-07-23.
Puma Biotechnology (PBYI) Research Hub
Puma Biotechnology (PBYI) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 9.12 USD (+0.77%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 15.86, market cap 0.42B. This hub links to the full technical, earnings and options research available for PBYI.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 9.12 USD (+0.77%) |
| 52-week range | 7 USD – 9.72 USD |
| Trend regime | Range |
| 14-day RSI | 54 (Neutral) |
| Trailing P/E | 15.86 |
| Market cap | 0.42B |
| Dividend yield | 0.00% |
Available research for PBYI
Covered Call on PBYI: how it works, illustrative setup around the real 9.12 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on PBYI: how it works, illustrative setup around the real 9.12 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on PBYI: how it works, illustrative setup around the real 9.12 USD price, max profit/loss, breakeven and when to use it. Educational.
PBYI technical analysis: range, last 9.12 USD, RSI 54, 52w range 7 USD–9.72 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is PBYI in?
Puma Biotechnology (PBYI) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is PBYI in an uptrend or downtrend?
As of 2026-09-11, PBYI is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is PBYI's trailing P/E ratio?
PBYI's trailing P/E is 15.86, with a market cap of 0.42B. See the earnings research page for full valuation detail.